Cargando…
Cisplatin and S‐1 for urachal carcinoma: A single‐institution case series
INTRODUCTION: Urachal carcinoma is a rare cancer, manifesting predominantly as adenocarcinoma, and could be treated with chemotherapy in patients with advanced or recurrent disease. However, any standard chemotherapy regimens are yet to be determined. CASE PRESENTATION: We retrospectively reviewed f...
Autores principales: | Urasaki, Tetsuya, Naito, Yoichi, Matsubara, Nobuaki, Sasaki, Masaoki, Kogawa, Takahiro, Hosono, Ako |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292134/ https://www.ncbi.nlm.nih.gov/pubmed/32743398 http://dx.doi.org/10.1002/iju5.12066 |
Ejemplares similares
-
Intestinal Perforation due to Neutropenic Enterocolitis in a Patient Treated with Bevacizumab for Ovarian Cancer
por: Sasaki, Akinori, et al.
Publicado: (2020) -
Use of eribulin as an earlier-line chemotherapy for patients with HER2-negative metastatic breast cancer
por: Shingaki, Sumito, et al.
Publicado: (2020) -
Brain metastasis from urachal carcinoma
por: Takahara, Kento, et al.
Publicado: (2019) -
Follicular dendritic cell sarcoma treated with a variety of chemotherapy
por: Sasaki, Masaoki, et al.
Publicado: (2016) -
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis
por: Funasaka, Chikako, et al.
Publicado: (2021)